{
  "id": 5166949,
  "title": "DR Congo Ebola vaccine trials to begin by November: WHO",
  "url": "https://urgent.news/2026/09/02/dr-congo-ebola-vaccine-trials-to-begin-by-november-who",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T20:20:03.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-dr-congo-ebola-vaccine-trials.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The World Health Organization (WHO) announced that trials for three potential Ebola vaccines against the strain responsible for the deadliest outbreak in Democratic Republic of Congo (DRC) will begin by October or November. The DRC's 17th Ebola outbreak, declared in May, has resulted in over 3,000 deaths and more than 6,000 infections. The WHO believes the virus may have begun spreading as early as late January. Currently, there are no approved vaccines or treatments for the Bundibugyo species of Ebola behind the outbreak. Two new vaccines against Bundibugyo virus are currently in safety trials in the U.K. and Canada, while the WHO has recommended a full-scale human trial of Ervebo, a vaccine approved for the more common Zaire strain, to assess its potential cross-protection against Bundibugyo.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}